M V22 (Hydrochlorothiazide and valsartan 12.5 mg / 160 mg)

Pill imprint M V22 has been identified as Hydrochlorothiazide and valsartan 12.5 mg / 160 mg.

Hydrochlorothiazide/valsartan is used in the treatment of high blood pressure and belongs to the drug class angiotensin II inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/valsartan 12.5 mg / 160 mg is not a controlled substance under the Controlled Substance Act (CSA).

Hydrochlorothiazide and valsartan

Imprint:

M V22

Strength:

12.5 mg / 160 mg

Color:

Orange

Shape:

Round

Availability:

Prescription only

Drug Class:

Angiotensin II inhibitors with thiazides

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Manufacturer:

Mylan Pharmaceuticals Inc.

National Drug Code (NDC):

00378-6322

Inactive Ingredients:

silicon dioxide
crospovidone
hypromelloses
ferric oxide red
lactose monohydrate
magnesium stearate
ferric oxide yellow
microcrystalline cellulose
polydextrose
polyethylene glycol
povidone
corn starch
sodium lauryl sulfate
titanium dioxide
triacetin

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
51079-0193	UDL Laboratories Inc

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.